• Event Type: Earnings conference call to discuss financial performance
  • Date and Time: Call was held on Thursday, October 29, 2026 (time not specified)
  • Financial Periods Discussed: Q2 FY27 and H1 FY27 (Second Quarter and First Half of Financial Year 2027)
  • Recording Availability: Audio recording is available at https://senorespharma.com/investor-meet/
  • Regulatory Context: This submission follows previous intimations dated October 22, 2026 and October 23, 2026 regarding the earnings call
  • Management Participants: Not specified in this disclosure
  • UPSI Statement: The document does not contain any statement regarding unpublished price sensitive information

Additional Notes Section

  • Document Purpose: Formal submission to BSE and NSE listing departments for record-keeping purposes
  • Financial Data Disclosure: No financial figures or performance metrics are included in this regulatory filing
  • Attachments: No attachments mentioned beyond the audio recording link
  • Compliance Officer: Shilpa Sharma, Company Secretary & Compliance Officer (Membership Number: A34516) signed the submission